Journals / İzmir Tepecik Eğitim Hastanesi Dergisi / 2009 / Cilt: 19 - Sayı: 1

The relationship between respiratory parameters, exercise capacity and quality of life in patients with sarcoidosis

Sarkoidoz hastalarında solunumsal ölçütler ile egzersiz kapasitesi ve yaşam kalitesi arasındaki ilişki

Pages
1–7
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

FINDINGS: It was found that the most effected parameters among the pulmonary functions were Pimax% (53.46±21.80) and Pemax (69.73±18.81) values, and the six minute walking distance was reduced (436.91 ±84.37 m).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AIM: To investigate the relationship between the respiratory capacity, exercise capacity, and quality of life in sarcoidosis patients.
📊
Key Findings & Data:MATERIAL AND METHOD: Eleven patients who was followed as sarcoidosis and whose mean age was 51±12 (8F, 3M), were included.
💡
Conclusion & Impact:FINDINGS: It was found that the most effected parameters among the pulmonary functions were Pimax% (53.46±21.80) and Pemax (69.73±18.81) values, and the six minute walking distance was reduced (436.91 ±84.37 m).
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

AIM: To investigate the relationship between the respiratory capacity, exercise capacity, and quality of life in sarcoidosis patients. MATERIAL AND METHOD: Eleven patients who was followed as sarcoidosis and whose mean age was 51±12 (8F, 3M), were included. The pulmonary function test (FEV], FVC, FEV]/FVC, DLCO), respiratory muscle strength (Pimax, Pemax), general health-related and disease-spesific quality of life (SF-36 and St. George Quality of Life Questionnaires), exercise capacity (six-minute walking test), dyspnea and fatigue severity (Modified Borg Scale) were evaluated. FINDINGS: It was found that the most effected parameters among the pulmonary functions were Pimax% (53.46±21.80) and Pemax (69.73±18.81) values, and the six minute walking distance was reduced (436.91 ±84.37 m). It was determined that the pulmonary capacity, exercise capacity and quality of life parameters were correlated with each other (p<0.05). CONLUSION: According to our results, exercise capacity and respiratory muscle strength of the patients with sarcoidosis were extremelly reduced. For this reason, it is considered that the assessment of the respiratory muscle strength and exercise capacity from the early period of the disease in the routine clinical evaluation could be helpful. It is suggested that pulmonary rehabilitation programs, which improve exercise capacity and quality of life, could be added into the standard medical treatment of patients with sarcoidosis.

Özet

AMAÇ: Sarkoidoz'lu hastalarının solunumsal ölçütleri ile egzersiz kapasitesi ve yaşam kaliteleri arasındaki ilişkiyi inceledik. GEREÇ VE YÖNTEM: Çalışmaya sarkoidoz tanısıyla izlenen yaş ortalaması 51±12 olan 11 olgu (8K, 3E) alındı. Hastaların solunum fonksiyon testleri (ZEVb ZVK, ZEVyZVK, KMDK), solunum kas kuvveti (Pimax, Pemax) genel sağlıkla ilgili ve hastalığa özel yaşam kaliteleri (Kısa Form-36 ve St. George Kronik Solunum Hastalıkları Anketi ile), egzersiz kapasiteleri (6 dakika yürüme testi ile), dispne ve yorgunluk şiddetleri (Modifıye Borg Skalası ile) değerlendirildi. BULGULAR: Olguların 6'sında günlük yaşamları boyunca solunum sıkıntısı, 3'ünde öksürük yakınmaları olduğu bulundu. Hastaların solunum fonksiyonları arasında en fazla etkilenimin Pimax% (53.46±21.80) ve Pemax% (69.73±18.81) değerlerinde olduğu ve egzersiz kapasitesinin bir göstergesi olan yürüme mesafelerinin (436.91±84.37 m) düşük olduğu bulundu. Solunum kapasitesi, egzersiz kapasitesi ve sağlıkla ilgili yaşam kalitesinin birbirleriyle ilişkili olduğu saptandı (p<0.05). SONUÇ: Sarkoidoz hastalarında özellikle egzersiz kapasitesi ve solunum kas kuvveti belirgin derecede azalmaktadır. Bu nedenlerle hastaların tanı aldıkları en erken dönemden itibaren rutin değerlendirmelerinde solunum kas kuvveti ve egzersiz kapasitesinin de değerlendirilmesinin yararlı olabilir ve egzersiz kapasitesi ve yaşam kalitesini arttırdığı kanıtlanmış olan pulmoner rehabilitasyon programlarının standart tedaviye eklenmesi uygun olabilir.

🔖

Cite This Article

ÖZALEVLİ, S., KARAALİ, K. H., ILGIN, D., TURAN, B. O., UÇAN, E. S. (2009). The relationship between respiratory parameters, exercise capacity and quality of life in patients with sarcoidosis. İzmir Tepecik Eğitim Hastanesi Dergisi, Cilt: 19 - Sayı: 1, 1–7. https://ajindex.com/articles/268470

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Baran A, Özşeker F, Güneylioğlu D, Bilgin S, Arslan S, Uyanusta Ç ve ark. Sarkoidoz: Yedi yıllık deneyim. Toraks Derg 2004
  2. 5 (3): 160-5. 2.Walder GP, Barros J, Alberto NC, Pereira LE. Clinical, radiographic and functional predictors of pulmonary gas exchange impairment at moderate exercise in patients with sarcoidosis. Respiration 2004
  3. Lamberto C, Nunes H, Le Toumelin P, Duperron F, Valeyre D, Clerici C. Membrane and capillary blood components of diffusion capacity of the lung for carbon monoxide in pulmonary sarcoidosis: relation to exercise gas Exchange. Chest 2004
  4. 125 (6): 2061-8. 4.Kabitz HJ, Lang F, Walterspacher S, Sorichter S, Müller-Quernheim J, Windisch W. Impact of impaired inspiratory muscle strength on dyspnea and walking capacity in sarcoidosis. Chest. 2006
  5. 130(5): 1496-502. 5.Wirnsberger RM, Drent M, Hekelaar N, Breteler MH, Drent S, Wouters EF et al. Relationship between respiratory muscle function and quality of life in sarcoidosis. Eur Respir J 1997
  6. 10 (7): 1450-5. 6.Michielsen HJ, Drent M, Peros-Golubicic T, De Vries J. Fatigue is associated with quality of life in sarcoidosis patients. Chest 2006
  7. Tabak L, Kılıçarslan Z, Kıyan E, Ereler M, Çuhadaroğlu Ç, Arseven O ve ark. 147 Sarkoidoz hastasının klinik özellikleri. Solunum 2001
  8. Barış İ. Solunum Hastalıkları Temel Yaklaşım: Barış İ. 3. Baskı. Ankara: Atlas Kitapçılık
  9. American Thoracic Society. Standardization of spirometry. Am J Respir Crit Care Med 1995:152
  10. Mahler DA, Wells CK. Evaluating of clinical methods for rating dyspnea. Chest 1988
  11. ATS Statement. ATS Statement: Guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002: 111-7. 12.Brazier J, Harper R, Jones N, O'Cathain A, Thomas K, Usherwood T et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 1992: 305
  12. Demiral Y, Ergor G, Ünal B, Semin S, Akvardar Y, Kivircik B et al. Normative data and discriminative properties of short form 36 (SF-36) in Turkish urban population. BMC Public Health 2006
  13. 9(6):247. 14.Zugid V, Videnovi6-Ivanov J, Gvozdenovic B. St. George's respiratory questionnaire (SGRQ) in sarcoidosis patients. Med Pregl 2005
  14. 58(1): 71-4. 15.Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St, George's Respiratory Questionnaire. Am Rev Respir Dis 1992
  15. 145 (6): 1321-7. 16.Medinger AE, Khouri S,